XRX is down more than -14% since mid-January. Is it a good bargain?

One of the big challenges for average investors is sifting through the mountains of information that comes from the market on a daily basis. I think that may be the biggest reason that so many investors have learned over the course of decades of market activity to rely on analyst estimates for a company’s future prospects. As both an analyst and an investor, I actually find the idea a little be ironic, because predicting the future in any context is nothing more than pure guesswork, and any success comes by nothing but sheer luck – but we still keep trying to do it anyway.

That tendency to rely on future estimates is one of the reasons that, a long time ago I started studying the principles of value-based analysis. That process led me to the writings of Benjamin Graham, who is widely credited as the father of fundamental analysis and well-known as the man who taught a young Warren Buffett the basic principles that still drive his investment philosophy today. One of the primary takeaways for me was the way that Mr. Graham doesn’t use future estimates in his analysis. He preferred to boil his investment decision to a simple question: is the company’s book of business worth more than its stock price today? If the answer was yes, the stock was worth consideration as a long-term investment. The larger the difference between a company’s value and its actual stock price, the more compelling the argument became. Estimates about the future don’t figure into that question, or its answer, at all.

The question of how to determine the value of a company’s book of business has a lot of different possible answers. While Mr. Graham’s original data points for finding that number have become dated, the basic principles he described nearly a hundred years ago still apply, and have become the foundation of the value-based system I use to identify my own investing opportunities, and that are the core of the analysis I write about every day in this space.

Now to the stock I’m using to for today’s post. Xerox Holdings Corporation (XRX) is a company that I have followed for some time, and that I have used to pretty nice effect on a number of occasions over the last few years – even during the ongoing pandemic, when the entire Business Services industry this company operates in has struggled as practically all of corporate America has been forced to shift to remote workforce operations and the services that support them. For a business that largely relies on traditional, in-office operations, that means that XRX has been focusing extensively on cost controls to survive the worst pandemic-driven effects in order to survive.

XRX’s earnings reports for most of the past two years have indicated big impacts on their business from the COVID-19 pandemic; in fact, in the most recent report released just about a week ago, management pointed to omicron-driven shortages in the supply chain that significantly affected basic metrics like earnings and net income. The stock has followed a strong downward trend for most of the past year that finally found a bottom at around $17.50 in early November. After staging a strong rally to around $24 per share in mid-January, the stock capitulated to broad market momentum and began dropping. That momentum was also fueled by management’s acknowledgement of the recent COVID-driven pressures on their quarterly results, and have now pushed the stock down to a little above the $20 level. While there are some concerns, XRX also has some clear elements of fundamental strength. Are they enough to suggest that analysts and the market have overreacted? If so, that should also mean that XRX’s value profile could be even better than it was before. Let’s dive in.

Fundamental and Value Profile

Xerox Corporation is a provider of digital print technology and related solutions. The Company has capabilities in imaging and printing, data analytics, and the development of secure and automated solutions to help customers improve productivity. The Company’s primary offerings span three main areas: Managed Document Services, Workplace Solutions and Graphic Communications. Its Managed Document Services offerings help customers, ranging from small businesses to global enterprises, optimize their printing and related document workflow and business processes. Managed Document Services includes the document outsourcing business, as well as a set of communication and marketing solutions. The Company’s Workplace Solutions and Graphic Communications products and solutions support the work processes of its customers by providing them with printing and communications infrastructure. XRX’s current market cap is about $3.3 billion.

Earnings and Sales Growth: Over the last twelve months, earnings declined more than -41%, while sales were nearly -8% lower. In the last quarter, earnings dropped over -29% while revenues were 1.08% higher. These metrics can be closely tied to the market’s reaction over the last few weeks, and the stock’s fall from grace over that period. XRX’s operating profile has shown a similar effect, as Net Income was -6.46% of Revenues over the last twelve months, with a significant deterioration to nearly -38% in the last quarter.

Free Cash Flow: XRX’s free cash flow is healthy, at about $561 million over the last twelve months. While that number decreased from $600 million in the last quarter, it also marks a significant improvement from $474 million a year ago; given the severity of the impact the pandemic has had, the net improvement is an interesting counter to the weakness reflected by the declining Net Income metrics I just mentioned. The current Free Cash Flow number also translates to a useful Free Cash Flow Yield of 15.31%. It is also worth noting that XRX’s Free Cash Flow was $0 in June of 2018, with the company showing consistent improvement in this critical metric from that point until 2020.

Debt to Equity: XRX has a debt/equity ratio of .81. That’s generally a conservative number that reflects management’s careful approach to debt management. Since the beginning of 2018, the company’s long-term debt has decreased from a little more than $5.2 billion to its current level of $3.5 billion (down from $4.2 billion two quarters ago). Their balance sheet also shows more than $2.2 billion in cash and liquid assets, which means that servicing their debt isn’t a problem, and for now provides an important buffer, especially since operating profits indicate the company has been spending more than they have brought in.

Dividend: XRX pays a dividend of $1.00 per share, which translates to an annual yield of 4.87% at the stock’s current price.

Price/Book Ratio: there are a lot of ways to measure how much a stock should be worth; but I like to worth with a combination of Price/Book and Price/Cash Flow analysis. Together, these measurements provide a long-term target at about $22 per share, suggesting that the stock is undervalued by 8% at its current price, with a practical discount price at around $17.50. An interesting side note is the fact that XRX has a current Book Value of $27.83 per share – which is about 35% above the stock’s current price.

Technical Profile

Here’s a look at the stock’s latest technical chart.

Current Price Action/Trends and Pivots: The diagonal red line traces the stock’s downward trend from its 52-week high at around $27 in March of last year to its October low at around $17.50. It also provides the baseline for the Fibonacci retracement lines shown on the right side of the chart. From November to mid-January, the stock surged to a peak at around $24, a little above the 61.8% retracement line before picking up a new, significant wave of bearish momentum that pushed the stock quickly down to the $20 range, where it has been holding steady for the past four or five trading days to mark current support. Immediate resistance looks to be at around $21, inline with the 38.2% retracement line. A push above $21 could mark a useful point to reverse the current short-term trend and provide upside to around the 61.8% line in the $23 to $24 range. A drop below current support at $20 could see the stock fall to anywhere between its 52-week low at $17.50 and $18 before finding next support.

Near-term Keys: XRX’s value proposition is interesting, but not as useful right now as it would need to be to mark XRX as a truly useful value-based opportunity. That also means that the best probabilities to work with this stock right now lie in short-term trades. If you prefer to use momentum-driven trading strategies you could consider using a drop below $20 to short the stock or buy put options, with a practical target price at around $18 per share. A push above $21 could provide a good signal to think about buying the stock or working with call options, with $23 to $24 providing a nice, quick-hit profit target for a bullish trade.

Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Oil Field Machinery Stocks To Buy Now

    Matrix Service Company (MTRX) Matrix Service Company provides engineering, fabrication, construction, and maintenance services to energy and industrial markets. The company operates through segments such as Storage and Terminal Solutions,... Read More

  • 3 Restaurant Stocks To Buy Now

    Brinker International, Inc. (EAT) Brinker International, Inc. is a leading casual dining restaurant company, operating well-known brands such as Chili’s Grill & Bar and Maggiano’s Little Italy. The company focuses... Read More

  • 3 Coal Stocks To Buy Now

    Natural Resource Partners L.P. (NRP) Natural Resource Partners L.P. is a master limited partnership that owns, manages, and leases a diversified portfolio of mineral properties in the United States. The... Read More

  • 3 Real Estate Developer Stocks To Buy Now

    IRSA Inversiones y Representaciones Sociedad Anónima (IRS) IRSA Inversiones y Representaciones Sociedad Anónima is a leading real estate company in Argentina, engaged in the acquisition, development, and management of diversified... Read More

  • 3 Gas Distribution Stocks To Buy Now

    New Jersey Resources Corporation (NJR) New Jersey Resources Corporation is an energy services holding company that provides regulated natural gas distribution services through its subsidiary, New Jersey Natural Gas. The... Read More

  • 3 Food Product Stocks To Buy Now

    The Chefs’ Warehouse, Inc. (CHEF) The Chefs’ Warehouse, Inc. is a premier distributor of specialty food products, serving high-end restaurants, hotels, and gourmet food stores across the United States and... Read More

  • 3 HVAC Stocks To Buy Now

    Featured Content Lennox International Inc. (LII) Lennox International Inc. is a global leader in energy-efficient climate control solutions, specializing in heating, ventilation, air conditioning, and refrigeration (HVACR) products. The company... Read More

  • 3 Hotel Stocks To Buy Now

    Featured Content Hyatt Hotels Corporation (H) Hyatt Hotels Corporation operates a global portfolio of luxury, full-service, and lifestyle hotels, as well as vacation properties. Known for its premium hospitality offerings,... Read More

  • 3 Tobacco Stocks To Buy Now

    Featured Content Turning Point Brands, Inc. (TPB) Turning Point Brands, Inc. is a consumer products company that manufactures and markets tobacco products and alternative smoking accessories. The company’s portfolio includes... Read More

  • 3 Life Insurance Stocks To Buy Now

    Featured Content F&G Annuities & Life, Inc. (FG) F&G Annuities & Life, Inc. specializes in annuities and life insurance products designed to meet the long-term financial planning needs of clients.... Read More

  • 3 Soft Beverage Stocks To Buy Now

    Featured Content Westrock Coffee Company (WEST) Westrock Coffee Company is a leading integrated coffee, tea, and extract service provider, offering comprehensive solutions from sourcing and roasting to packaging and distribution.... Read More

  • 3 Medical Info System Stocks To Buy Now

    Featured Content Clover Health Investments, Corp. (CLOV) Clover Health Investments, Corp. is a healthcare technology company focused on improving health outcomes for America’s seniors. The company offers Medicare Advantage plans... Read More